Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.786 EUR | -0.63% |
|
-5.72% | -2.90% |
01/05 | Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024 | |
01/05 | Chimerix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 34 | 100.0 % | 0 | 100.0 % | -99.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 34 | 100.0 % | 0 | 100.0 % | -99.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Andriole
CEO | Chief Executive Officer | 51 | 08/19/08 |
Director of Finance/CFO | 50 | 01/11/01 | |
Michael Sherman
CHM | Chairman | 58 | 08/19/08 |
Caryn Barnett
CTO | Chief Tech/Sci/R&D Officer | - | 01/20/01 |
Allen Melemed
CTO | Chief Tech/Sci/R&D Officer | 60 | 22/20/22 |
Joshua Allen
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Thomas Riga
COO | Chief Operating Officer | 48 | 16/11 |
General Counsel | - | 08/22/08 | |
David Jakeman
AUD | Comptroller/Controller/Auditor | 47 | 01/09/01 |
Roy W. Ware
PRN | Corporate Officer/Principal | - | 01/07/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Middleton
BRD | Director/Board Member | 74 | 28/18/28 |
Martha Demski
BRD | Director/Board Member | 71 | 01/05/01 |
Michael Sherman
CHM | Chairman | 58 | 08/19/08 |
Pratik Multani
BRD | Director/Board Member | 57 | 24/20/24 |
Robert Meyer
BRD | Director/Board Member | 65 | 28/18/28 |
Lisa Decker
BRD | Director/Board Member | 55 | 28/12 |
Director/Board Member | 60 | 26/21/26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 89,629,902 | 83,667,912 ( 93.35 %) | 0 | 93.35 % |
Company contact information
![address Chimerix, Inc.(CXF)](https://cdn.zonebourse.com/static/address/50918364.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.58% | 12TCr | |
+16.60% | 11TCr | |
+17.55% | 2.62TCr | |
-24.33% | 1.9TCr | |
-19.14% | 1.57TCr | |
-17.95% | 1.52TCr | |
-46.81% | 1.47TCr | |
+58.78% | 1.46TCr | |
+4.91% | 1.38TCr |
- Stock Market
- Equities
- CMRX Stock
- CXF Stock
- Company Chimerix, Inc.